← Evidence map

ReviewJournal of obesity & metabolic syndrome2021

Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for Clinical Practice?

Donna H RyanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34518444